cohen private ventures, LLC

111 eighth avenue
new york, new york 10011

NYS Entity Status
ACTIVE

NYS Filing Date
MARCH 14, 2014

NYS DOS ID#
4544717

County
NEW YORK

Jurisdiction
DELAWARE

Registered Agent
NONE

NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY

Name History
2014 - COHEN PRIVATE VENTURES, LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Angeles Equity Partners Adds Three New Team Members
    By Business Wire - Tuesday Aug 15, 2017

    Angeles Equity Partners, LLC (AEP), a private investment firm focused on value creation through operational transformation, today announced three new professionals have joined the firm. Maxwell Schechter joins the firm as Vice...

    Source: VentureBeat
  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • The Hunt: A Private Roof Deck on the Upper West Side
    By JOYCE COHEN - Thursday Jun 8, 2017

    A couple wanted outdoor space, and found it, but at the top of a walk-up building.

    Source: NYT > Home Page
  • Trump admin blocks Chinese buyer from taking over US tech firm
    By Bob Fredericks - Wednesday Sep 13, 2017

    Citing national security concerns, President Trump on Wednesday blocked a Chinese-backed investor from buying Lattice Semiconductor Corp. — only the fourth time a president has stopped a foreign takeover in 27 years. The would-be buyer, Canyon Bridge Capital Partners LLC, is a private-equity firm backed by a Chinese state-owned asset manager, Bloomberg reported. “Consistent with...

    Source: New York Post: Business
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
cohen private ventures llc new york ny